Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1311-1320 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|March 17, 2006
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistanceM Lauten, A Schrauder, C Kardinal, et al.
Leukemia|March 25, 2006
Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineageY Hong, G Wang, A Gutierrez Del Arroyo, et al.
Leukemia|December 21, 2007
Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMPI Abecassis, J Maes, J-L Carrier, et al.
Leukemia|December 21, 2007
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromesM G Della Porta, L Malcovati, G M Rigolin, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Leukemia|May 30, 2008
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphomaJ Dien Bard, P Gelebart, M Anand, et al.
Leukemia|December 15, 2007
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell linesS Nagel, C Meyer, H Quentmeier, et al.
Leukemia|February 4, 2014
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunitiesS Fulda
Leukemia|January 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaCedric S Tremblay, Jesslyn Saw, Feng Yan, et al.
Leukemia|February 5, 2025
STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphomaQiangqiang Shao, Karan Bedi, Isabella A Malek, et al.
Pageof 963

Showing results (1311-1320 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|March 17, 2006
Unsupervised proteome analysis of human leukaemia cells identifies the Valosin-containing protein as a putative marker for glucocorticoid resistanceM Lauten, A Schrauder, C Kardinal, et al.
Leukemia|March 25, 2006
Comparison between anagrelide and hydroxycarbamide in their activities against haematopoietic progenitor cell growth and differentiation: selectivity of anagrelide for the megakaryocytic lineageY Hong, G Wang, A Gutierrez Del Arroyo, et al.
Leukemia|December 21, 2007
Re-expression of DNA methylation-silenced CD44 gene in a resistant NB4 cell line: rescue of CD44-dependent cell death by cAMPI Abecassis, J Maes, J-L Carrier, et al.
Leukemia|December 21, 2007
Immunophenotypic, cytogenetic and functional characterization of circulating endothelial cells in myelodysplastic syndromesM G Della Porta, L Malcovati, G M Rigolin, et al.
Leukemia|December 21, 2007
Prevention of thalidomide- and lenalidomide-associated thrombosis in myelomaA Palumbo, S V Rajkumar, M A Dimopoulos, et al.
Leukemia|May 30, 2008
Aberrant expression of IL-22 receptor 1 and autocrine IL-22 stimulation contribute to tumorigenicity in ALK+ anaplastic large cell lymphomaJ Dien Bard, P Gelebart, M Anand, et al.
Leukemia|December 15, 2007
MEF2C is activated by multiple mechanisms in a subset of T-acute lymphoblastic leukemia cell linesS Nagel, C Meyer, H Quentmeier, et al.
Leukemia|February 4, 2014
Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunitiesS Fulda
Leukemia|January 23, 2025
Targeting LMO2-induced autocrine FLT3 signaling to overcome chemoresistance in early T-cell precursor acute lymphoblastic leukemiaCedric S Tremblay, Jesslyn Saw, Feng Yan, et al.
Leukemia|February 5, 2025
STAT6 mutations compensate for CREBBP mutations and hyperactivate IL4/STAT6/RRAGD/mTOR signaling in follicular lymphomaQiangqiang Shao, Karan Bedi, Isabella A Malek, et al.
Pageof 963